Suchergebnisse - "Nieboer, Daan"

PubPharm (14)

1

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death : Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

enthalten in: European urology | 2023

von Remmers, S. | Bangma, C. | Godtman, R. | +18

CommentIn: Transl Androl Urol. 2024 Mar 31;13(3):473-475. - PMID 38590968

2

Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer : An analysis of the G.A.P.3 global consortium database

enthalten in: The Prostate | 2022

von Beckmann, K. | Bangma, C. | Helleman, J. | +83

3

Improving the prediction of biochemical recurrence after radical prostatectomy with the addition of detailed pathology of the positive surgical margin and cribriform growth

enthalten in: Annals of diagnostic pathology | 2022

von Remmers, S. | Hollemans, E. | Nieboer, D. | +4

4

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance

enthalten in: BJU international | 2021

von Tomer, A. | Nieboer, D. | Roobol, M. | +76

5

Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies

enthalten in: Cancer medicine | 2020

von Li, W. | Denton, B. | Nieboer, D. | +4

6

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs

enthalten in: Medical decision making : an international journal of the Society for Medical Decision Making | 2019

von Tomer, A. | Rizopoulos, D. | Nieboer, D. | +3

7

A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer : Adjustment of PHI Reference Ranges is Needed for European and Asian Settings

enthalten in: European urology | 2019

von Chiu, P. | Ng, C. | Semjonow, A. | +20

CommentIn: Eur Urol. 2019 Jun;75(6):e158-e159. - PMID 30616947

8

Reasons for Discontinuing Active Surveillance : Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium

enthalten in: European urology | 2019

von Van Hemelrijck, M. | Ji, X. | Helleman, J. | +92

CommentIn: J Urol. 2020 Feb;203(2):252-253. - PMID 31710568

9

Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7

enthalten in: Histopathology | 2018

von Verhoef, E. | Kweldam, C. | Kümmerlin, I. | +6

10

Prediction of Prostate Cancer : External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort

enthalten in: European urology focus | 2018

von Gayet, M. | Mannaerts, C. | Nieboer, D. | +4